| |
|
|
|
|
|
|
|||
|
DL Gumucio, WK Lockwood, JL Weber, AM Saulino, K Delgrosso, S Surrey, E Schwartz, M Goodman and FS Collins
Department of Internal Medicine, University of Michigan, Ann Arbor
48109-0650.
A point mutation at position -175 has been detected in Agamma as well as
Ggamma globin genes in individuals with hereditary persistence of fetal
hemoglobin (HPFH). To prove that this single point mutation results in
increased promoter strength, we transfected erythroid and nonerythroid cell
lines with constructs containing normal and mutant promoters linked to the
bacterial chloramphenicol acetyl transferase (CAT) gene. Differences in
transfection efficiency were controlled by cotransfection of pRSVgpt. In
K562 erythroleukemia cells, the -175 HPFH promoter directed three- to
fourfold more CAT activity than its wild type counterpart. However, in HeLa
cells the two promoters were similar in strength. The -195 to -165 region
of the gamma-globin promoter contains binding sites for two proteins: a
ubiquitously distributed octamer binding protein, OBP, and the
erythroid-specific protein, GF-1. We find that while the GF-1 binding site
is highly conserved among related primate gamma-globin genes, the octamer
binding site is not. The evolutionary conservation of GF-1 as well as its
erythroid-specific distribution suggest that this protein is important in
gamma-globin gene expression. A role for OBP in the regulation of
gamma-globin, if any, must have arisen recently in primate evolution.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1990 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||